The RUNX1-associated microRNA profile was also noteworthy, as it included the miR-155 and miR-130a families, which were expressed with RUNX1. The up-regulation of miR-155 was associated with an unfavorable clinical outcome independently in CN-AML. This evidence concerns the gene RUNX1 and acute myeloid leukemia.